Physician profile
James Bowen
NPI 1225679103
$395.11
in general payments reported to CMS, 2019-2025
11 companies · $88.60 in 2025
The $88.60 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $55.73 · 2022: $56.47 · 2023: $84.56 · 2024: $110 · 2025: $88.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $282.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $59.14 | 2021-2023 | |
| Inari Medical, INC. | $54.19 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.36 | 2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $46.53 | 2022-2023 | |
| Stryker Corporation | $46.39 | 2025 | Flowtriever |
| Astrazeneca Pharmaceuticals LP | $29.51 | 2021-2023 | Lokelma |
| Abbvie INC. | $28.46 | 2021 | |
| Boston Scientific Corporation | $27.20 | 2024 | Watchman Flx |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.07 | 2025 | Xifaxan |
| Smith+Nephew, INC. | $18.14 | 2025 | Collagenase Santyl |
| Janssen Pharmaceuticals, INC | $14.12 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Bowen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.